Novel Strategies to Advance Biotherapeutic Development

Symposium: Advances in Analytical and Bioanalytical Platform Technology

Moderator(s)

• 

  Shoshana Oberstein (she/her/hers)

  Manager, Labs (R&D)
  PPD, part of Thermo Fisher Scientific
  Richmond, Virginia

Presentations:

• 9:30 AM – 10:00 AM PT

  Personalizing Clinical Immunogenicity Risk Through HLA DR Alleles Associations
  

  Speaker: SURENDRAN RAJENDRAN, PhD (he/him/his) – Bristol-Myers Squibb
• 10:00 AM – 10:30 AM PT

  Unique Clinical Pharmacology Considerations for Allogeneic Cell Therapies
  

  Speaker: Dhruvitkumar Sutaria, PhD (he/him/his) – Genentech
• 10:30 AM – 11:00 AM PT

  Methodologies for Biotherapeutic Biotransformation Studies
  

  Speaker: Anton Rosenbaum – AstraZeneca